Cost-Effective Interventions to Curb Non- Communicable Diseases and Injury Chair: Karen-Helene Ulltveit-Moe, University of Oslo Presenter: Gavin Yamey,

Slides:



Advertisements
Similar presentations
1 Translation of Research Findings for Prevention and Control of NCDs Shanthi Mendis Chronic Disease Prevention and Management World Health Organization.
Advertisements

NCCP WHO 1995 Regional tumour registry, Lund October 1995 Primary prevention - tobacco Education Schoolchildren from age 10 years Promote peer-to-peer.
Global Health 2035: Implications for Economic Policy Lawrence H. Summers Charles W. Eliot University Professor, Harvard University Presentation at IMF,
International Health Policy Program -Thailand Suladda Pongutta February 20, 2010 IHPP Comparison between Thai NHA Obesity Strategy and WHO Expert Technical.
Dr. Sevil Huseynova World Health Organization
Non Communicable Disease
Chapter Twelve Importance of Noncommunicable Disease.
Non communicable diseases Thomas Abraham. What are non- communicable diseases? How big a problem are they? Sources of information Challenges in reporting.
WHO GLOBAL ALCOHOL STRATEGY
Gavin Yamey MD MPH Associate Professor of Epidemiology & Biostatistics, UCSF School of Medicine Lead, Evidence to Policy Initiative, Global Health Group,
The Contribution of Mental Health Services to Tackling Health Inequalities Dr Alastair Cook Chair RCPsych in Scotland.
Course 17: Neglected Tropical Diseases & NCDs 9 th GA of IAPB Hyderabad; 19 th September 2012 NCDs & Eye Health Converging interests and opportunities.
Tt HRB Centre for Health and Diet Research The burden of hypertension Ivan J Perry, Dept. of Epidemiology and Public Health, University College Cork. Institute.
Synergies for NCDs and CDs in a post 2015 context Director of Development Susanne Volqvartz The Danish NCD Alliance.
WHO - Global and regional NCD commitments
Combating disease and improving health Presented by ROSANNA AGBLE at Taking Action for the World’s Poor and Hungry People Beijing, China October 17–19,
Diabetes and the Heart Meet the experts August Responding to the challenge: determining health policy Introductory remarks Lars Rydén Department.
Evidence-based/Best Practices Tobacco Control Hadii Mamudu, PhD, MPA COPH-China Institute November 17, 2011.
1 NON COMMUNICABLE DISEASES NORTH -WESTERN PROVINCE Dr.M.D.S.RAJAMANTHRIE DPDHS Kurunegala Dr. D.I.WIJAYAWARDANA Medical Officer Planning PDHS Office.
Addressing the Challenge of NCDs in LAC: Brazil Country Case Study Isabella Danel Christoph Kurowski.
Integration of 5 Public Health Programs Jan Norman, RD, CDE Chronic Disease Prevention Unit Washington State Department of Health.
Bringing Agriculture to the Table September 19, 2011 September 19, Bringing Agriculture to the Table How Agriculture and Food Can Play a Role in.
1 |1 | Conclusions of the Physical Activity Working Group Dr Godfrey Xuereb Team Leader Population-based Prevention Department of Chronic Diseases and.
WHO Technical Briefing Seminar on Essential Medicines & Health Products, October 2013 Noncommunicable Diseases –Action Plan Dr Shanthi Mendis Director,
Dr Godfrey Xuereb Team Leader Surveillance and Population-based Prevention Department for the Prevention of NCDs A comprehensive global monitoring framework.
Act globally, think locally Tobacco control in the Pacific Matthew Allen Allen & Clarke, New Zealand.
NHPA’s. What are they? National Health Priority Areas (NHPAs) are diseases and conditions chosen for focused attention at a national level because of.
Public Health. What is public health? The prevention of disease and promotion of health through organized efforts and education of society and individuals.
International Health Policy Program -Thailand Phusit Prakongsai, MD. Ph.D. Walaiporn Patcharanarumol, MSc. Ph.D. Viroj Tangcharoensathien, MD. Ph.D. International.
Professor Judith Mackay Plenary Session 4 - Chronic Disease World Congress of Epidemiology Edinburgh, Scotland; 9 August 2011.
The Rising Prevalence of NCDs: Implications for Health Financing and Policy Charles Holmes, MD, MPH Office of the U.S. Global AIDS Coordinator Department.
Dr. Joseph Mbatia Assistant Director and Head, NCD, Mental Health and Substance Abuse Ministry of Health and Social Welfare (Tz. Mainland)
The Commission on Investing in Health Lawrence Summers, Chair Dean Jamison, Co-Chair February 2, 2015.
Affordable Care Act: Implications for Public Health Marty Fenstersheib, MD, MPH Health Officer Santa Clara County.
Global Alliance against Chronic Respiratory Diseases GARD/NCD Action Plan & 2011 UN Summit on NCDs Niels H. Chavannes MD PhD Associate.
INJURY EPIDEMIOLOGY & PREVENTION. Definitions Injury “Acute exposure to physical agents such as mechanical energy, heat, electricity, chemicals, and ionising.
National Center for Chronic Disease Prevention and Health Promotion
Disease Control Priorities 3 rd Edition REPRODUCTIVE, MATERNAL, NEWBORN & CHILD HEALTH [NAME] [AFFILIATION] [EVENT OR MEETING]
Definition of the ‘health transition’ Trends of disease patterns in populations The 4 stages of the epidemiological transition The cardiovascular disease.
Meeting the Challenge of Non-Communicable Diseases Lecture 14.
Public health and environment 1 |1 | Putting health at the heart of the Green Economy agenda _____ Making the links for Rio+20 Department of Public Health.
The Disease Control Priorities Project ( and Chronic Disease Presentation to the Hemispheric Meeting of the Social Protection.
The Burden of Chronic Diseases in the Developing World Stephen J. Spann, M.D., M.B.A. Professor and Chairman Department of Family and Community Medicine.
Non- communicable diseases in Pakistan. Air blue plane crash-152 died.
Chronic Disease A Public Health Perspective. Chronic Disease Overview The most prevalent, costly, and preventable chronic diseases –cardiovascular disease.
3rd NCD FLAG-PRO planning meeting Kaliningrad, 3 October 2011 FLAG-PRO A & B.
An Overview of the Burden of Non- Communicable Diseases (NCDs) Dr Sylvia J Anie Director Social Transformation Programmes Division (Education, Health,
Economic and Social Aspects of NCDs SDE Seminar Series/PAHO 25 April, 2012 Rachel Nugent.
Tobacco Control Policy Linda Waverley, MSc, PhD Research for International Tobacco Control (RITC) Insert your image here.
Nick Banatvala & Pascal Bovet

Components of a National Action Plan Ala Alwan Assistant Director-General World Health Organization 1.
NCD policy and programming in Croatia
Chronic NCDs in Sri Lanka : Policy to Public Health approaches
NON-COMMUNICABLE DISEASES – CURRENT SITUATION AND PREVENTION
DR GHULAM NABI KAZI WHO Country Office Pakistan
World Health Organization
World Health Organization
Non-Communicable Diseases Risk Factors Survey in Georgia
Global Health 2035: WDR Years
How does teamwork improve value. Dr Nils E
prevention and control of non communicable diseases in Iraq
World Health Organization
Noncommunicable diseases
Noncommunicable Diseases: Global Action - Global Response
Dhananjaya Perera, B.Sc. (Sp) Health Promotion
European Strategy for the Prevention and Control of Noncommunicable Diseases & Strategies for Promotion of Healthy Lifestyles St Petersburg. Russian Federation.
Non-communicable diseases (NCDs) I Obesity & Cancer
Global Burden of Tobacco
Dr Timothy Armstrong Coordinator
Presentation transcript:

Cost-Effective Interventions to Curb Non- Communicable Diseases and Injury Chair: Karen-Helene Ulltveit-Moe, University of Oslo Presenter: Gavin Yamey, University of California, San Francisco Discussants: Majid Ezzati, Imperial College London Richard Smith, UnitedHealth Group Cary Adams, NCD Alliance and CEO of UICC Global Health 2035 London Symposium Royal College of Physicians 3 December 2013

A paradox of success Deaths from selected important causes across different income levels

Age-standardized death rates from CVD are higher in all six World Bank regions than in HICs

What steps can countries take to delay onset? Relations between key risk factors for major NCDs and injuries † Amenable to drug therapy

Large loss of life expectancy Life expectancy  Smoking: smoker in U.S.  Loses about 10 y  Pollution: 65-y-old woman in moderately polluted Chinese city  Loses about 4 y  Obesity: 60-y-old with: BMI  Loses about 1-2 y BMI  Loses about 2-4 y BMI  Loses about 8-10 y

Essential packages of interventions Specific interventions in each package will vary by country  Depends on which risk factors dominate  Population package: reduces incidence of NCDs and injuries  Clinical package: reduces incidence and manages consequences Specific interventions in each package will vary by country  Depends on which risk factors dominate  Population package: reduces incidence of NCDs and injuries  Clinical package: reduces incidence and manages consequences

We structure our population-based package by policy instrument 1 Taxes and subsidies 2 Regulation and legislation 3 Information and communication 4 Built environment

Essential package of population-based interventions Taxes and subsidiesLaws and regulationsInformationBuilt environment TobaccoLarge (170%) excise taxes*Bans on use in public places and on promotion* Mass media messages* -- AlcoholLarge taxes in countries where high burden* Bans on promotion and restriction on sales* Mass media messages* -- Poor dietTax sugar and potentially other foods Bans on salt and trans fats in processed food* Increase public awareness of healthy diet and physical activity* -- Unsafe roads and vehicles --Enforce speeding and drink-driving laws --Safe roads and vehicles Air pollution Reduce fossil fuel subsidies. Selectively subsidise LPG to replace kerosene for household use. Promote LPG-- LPG=liquefied petroleum gas. *Represent WHO best buys for control of NCDs

Taxes: the single greatest opportunity is tobacco 50% rise in tobacco price from tax increases in China  prevents 20 million deaths + generates extra $20 billion/y in next 50 y  additional tax revenue would fall over time but would be higher than current levels even after 50 y  largest share of life-years gained is in bottom income quintile 50% rise in tobacco price from tax increases in China  prevents 20 million deaths + generates extra $20 billion/y in next 50 y  additional tax revenue would fall over time but would be higher than current levels even after 50 y  largest share of life-years gained is in bottom income quintile

Lessons from taxing tobacco and alcohol  Taxes must be large to change consumption  Must prevent tax avoidance (loopholes) and tax evasion (smuggling, bootlegging)  Design taxes to avoid substitution  Young/low-income groups respond most

Subsidies: the single greatest opportunity is ending fossil fuel subsidies Health and economic impacts Multiple NCDs cancers, heart disease, lung disease, respiratory infection Expenditures Subsidies (post-tax) were US $2.0 trillion in 2011 Energy subsidy reform is a crucial lever to curb NCDs

Three other policy instruments 2 Regulation and legislation Powerful, immediate government lever: ban industrially produced trans fats 3 Information and communication Dietary information improves knowledge but little evidence of behaviour change 4 Built environment Substituting solid fuels with cleaner technologies; electricity, LPG globalhealth2035.org

Essential package of clinical interventions WHO “best buys” NCDIntervention Liver cancerHepatitis B vaccine Cervical cancerVIA and treatment of pre- cancerous lesions CVD and diabetesCounselling and multi-drug therapy for high-risk patients Heart attackAspirin

We recommend scale-up in all countries Cost-effective 80% coverage by 2020 would avert 37% of global burden of cardiovascular disease Low coverage Except for hepatitis B vaccine, very low coverage across LICs/MICs Feasible 1 st step for all countries; costs $9bn/y; we argue that HPV vaccine should be included

Phased expansion pathways Choice of packages and expansion pathway will vary with pattern of disease, delivery capacity, domestic health spending

Why did we include childhood cancers?  Disease Control Priorities Project 3 rd edition examines evidence on treating pediatric cancers in a range of LICs/MICs  Treating common childhood malignancies in many settings would be cost-effective: treatments are effective and those cured can live for decades  Malawi: treating a single child with Burkitt lymphoma would be very cost-effective up to a cost of US $14,000 (actual cost of chemotherapy + supportive drugs is US $50) Hesseling PB. Burkitt lymphoma treatment: the Malawi experience. J Afr Cancer 2009;1:72–9.

Sudden price drops affect expansion pathway  For drugs, diagnostics, and vaccines, which can usually be delivered without complex infrastructure, price reductions can sometimes occur very rapidly  Price drop might be large enough for intervention to be used earlier in expansion pathway Price

“Interventions don’t deliver themselves” Community outreach ClinicsDistrict hospitalsReferral hospitals CVD, diabetesDiabetes prevention programmes Drugs for primary & secondary prevention of CVD Medical treatment of acute heart attack Angiography services CancersHPV vaccinationCervical cancer screening/treatment Hormonal therapy and surgery for breast cancer Treatment of selected paediatric cancers Psychiatric and neurological conditions Rehabilitation for chronic psychosis Antidepressants and psychotherapy for depression or anxiety Detoxification for alcohol dependence Neurosurgery for intractable epilepsy InjuriesTraining of lay first responders Treatment of minor burns Management of fractured femur Complex orthopaedic surgery—e.g. for pelvic injury

What role for international collective action? Curbing NCDs and Injuries Leadership and stewardship  Advocacy and technical assistance for taxation, trade and subsidy policies Provision of global public goods  “PPIR” (population, policy, and implementation research)  Expanding the menu of cost-effective population-based and clinical interventions  Surveillance on implementing the WHO FCTC Managing cross- border externalities Regional collaboration to prevent tobacco smuggling Direct country assistance Aid to LICs to support selected NCD and injury interventions (e.g. HPV and hepatitis B vaccines)

Thank you